These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 14092223)

  • 1. [IMPORTANCE OF THIAMINE (VITAMIN B1) FOR THE ASSIMILABILITY OF CREATININE BY CRYPTOCOCCUS NEOFORMANS].
    STAIB F
    Zentralbl Bakteriol Orig; 1963 Sep; 190():115-31. PubMed ID: 14092223
    [No Abstract]   [Full Text] [Related]  

  • 2. [MEMBRANE FILTRATION AND GUIZOTIA ABYSSINICA CULTURE MEDIA FOR THE DEMONSTRATION OF CRYPTOCOCCUS NEOFORMANS (BROWN COLOR EFFECT)].
    STAIB F
    Z Hyg Infektionskr; 1963 Oct; 149():329-36. PubMed ID: 14095025
    [No Abstract]   [Full Text] [Related]  

  • 3. Natural host resistance to infection with Cryptococcus neoformans. II. The influence of thiamine on experimental infection in mice.
    GADEBUSCH HH; GIKAS PW
    J Infect Dis; 1963; 112():125-33. PubMed ID: 13946046
    [No Abstract]   [Full Text] [Related]  

  • 4. UTILIZATION OF NITROGEN COMPOUNDS BY CRYPTOCOCCUS NEOFORMANS AND OTHER YEASTS.
    VANUDEN N; VIDAL-LEIRIA M; BUCKLEY HR
    Ann Soc Belges Med Trop Parasitol Mycol; 1964; 44():619-39. PubMed ID: 14309441
    [No Abstract]   [Full Text] [Related]  

  • 5. OCCURRENCE OF CRYPTOCOCCUS NEOFORMANS IN SWEDEN.
    BERGMAN F
    Acta Med Scand; 1963 Nov; 174():651-5. PubMed ID: 14082562
    [No Abstract]   [Full Text] [Related]  

  • 6. [THE CHANGE IN SHAPE OF THE TISSUE FORMS OF CRYPTOCOCCUS NEOFORMANS, SPOROTRICHUM SCHENCKII AND CANDIDA ALBICANS].
    BADER G; SCHABINSKI G
    Pathol Microbiol (Basel); 1963; 26():475-93. PubMed ID: 14046893
    [No Abstract]   [Full Text] [Related]  

  • 7. CYTOLOGICAL STRUCTURE OF CRYPTOCOCCUS NEOFORMANS.
    TSUKAHARA T
    Jpn J Microbiol; 1963 Aug; 7():53-60. PubMed ID: 14095979
    [No Abstract]   [Full Text] [Related]  

  • 8. CRYPTOCOCCUS NEOFORMANS POLYSACCHARIDE: STUDIES OF SEROLOGIC PROPERTIES AND ROLE IN INFECTION.
    BENNETT JE; HASENCLEVER HF
    J Immunol; 1965 Jun; 94():916-20. PubMed ID: 14321434
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cryptococcus neoformans, var. neoformans, Cryptococcus neoformans var. gattii, causative agents of cryptococcosis].
    Swinne D; Lumbila M
    Bull Mem Acad R Med Belg; 1987; 142(2-3):238-48. PubMed ID: 3311260
    [No Abstract]   [Full Text] [Related]  

  • 10. THE PREVALENCE AND MOUSE VIRULENCE OF CRYPTOCOCCUS NEOFORMANS STRAINS ISOLATED FROM URBAN AREAS.
    HASENCLEVER HF; EMMONS CW
    Am J Hyg; 1963 Sep; 78():227-31. PubMed ID: 14063725
    [No Abstract]   [Full Text] [Related]  

  • 11. THE ISOLATION OF CRYPTOCOCCUS NEOFORMANS (TORULA HISTOLYTICA) FROM SOIL IN NEW GUINEA AND PIGEON DROPPINGS IN SYDNEY, NEW SOUTH WALES.
    FREY D; DURIE EB
    Med J Aust; 1964 Jun; 1():947-9. PubMed ID: 14172402
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the biology of Cryptococcus. VI. Amino acid composition of the somatic proteins of Cryptococcus neoformans.
    UZMAN LL; ROSEN H; FOLEY GE
    J Infect Dis; 1956; 98(2):208-10. PubMed ID: 13319780
    [No Abstract]   [Full Text] [Related]  

  • 13. [Structure of Cryptococcus neoformans capsule].
    MOLNAR J
    Kiserl Orvostud; 1956 Sep; 8(5):498-501. PubMed ID: 13386051
    [No Abstract]   [Full Text] [Related]  

  • 14. Growth of Cryptococcus neoformans in a thiamine-free medium.
    Bruatto M; Vidotto V; Maina AM
    Mycopathologia; 1992 Sep; 119(3):129-32. PubMed ID: 1435953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Capsule synthesis by Cryptococcus neoformans.
    LITTMAN ML
    Trans N Y Acad Sci; 1958 May; 20(7):623-48. PubMed ID: 13556861
    [No Abstract]   [Full Text] [Related]  

  • 16. Preliminary observations on the phosphatases of Cryptococcus neoformans: a histochemical study.
    LIU YF
    Chin Med J; 1959 Aug; 79():138-42. PubMed ID: 14417618
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cryptococcosis. A contribution to the identification of Cryptococcus neoformans isolated from clinical specimens (author's transl)].
    Staib F; Randhawa HS; Grosse G; Blisse A
    Zentralbl Bakteriol Orig A; 1973 Dec; 225(2):211-22. PubMed ID: 4150053
    [No Abstract]   [Full Text] [Related]  

  • 18. Distribution of Cryptococcus neoformans in a pigeon habitat.
    Hubálek Z
    Folia Parasitol (Praha); 1975; 22(1):73-9. PubMed ID: 239886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific degradation of Cryptococcus neoformans 3723 capsular polysaccharide by a microbial enzyme. I. Isolation, partial purification, and properties of the enzyme.
    GADEBUSCH HH; JOHNSON JD
    Can J Microbiol; 1961 Feb; 7():53-60. PubMed ID: 13702836
    [No Abstract]   [Full Text] [Related]  

  • 20. THE INFECTION OF WHITE MICE FOLLOWING AN INTRANASAL INSTILLATION OF CRYPTOCOCCUS NEOFORMANS.
    RITTER RC; LARSH HW
    Am J Hyg; 1963 Sep; 78():241-6. PubMed ID: 14063727
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.